Puma Biotechnology
PBYI
PBYI
100 hedge funds and large institutions have $75.9M invested in Puma Biotechnology in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.58% less ownership
Funds ownership: 64.22% → 60.63% (-3.6%)
25% less capital invested
Capital invested by funds: $101M → $75.9M (-$25.1M)
Holders
100
Holding in Top 10
1
Calls
$166K
Puts
$57K
Top Buyers
| 1 | +$1.51M | |
| 2 | +$649K | |
| 3 | +$627K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$542K |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$346K |
Top Sellers
| 1 | -$4.85M | |
| 2 | -$835K | |
| 3 | -$718K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$652K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$551K |